Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Category list : Prescription-only medicines

Sort by: Newest first Oldest first A-Z Z-A

  • Shelf of medicines with prescriptions

    Prescription charge overhaul would raise £1bn a year for NHS, says think tank

    5 SEP 2014 15:16 By Elizabeth Sukkar
    Comments (2)

    A leading think tank is advising the government to review prescription charges in England to raise an additional £1bn a year to help fund NHS and social care in the future.

  • August SMC decisions Subscription

    11 AUG 2014 16:35

    The Scottish Medicines Consortium (SMC) has accepted the folllowing medicines for restricted use in NHS Scotland; dapagliflozin and metformin (Xigduo; AstraZeneca), ocriplasmin (Jetrea; Thrombogenics NV) and tocilizumab subcutaneous injection (RoActemra; Roche). The following medicines were rejected for use in NHS Scotland; colestilan (BindRen; Mitsubishi Pharma), lubiprostone soft capsules 24 micrograms (Amitiza; Sucampo), olodaterol solution for inhalation 2.5 microgram (Striverdi ...

  • The average number of prescription items issued per person has risen steadily from 13 per person per year in 2003 to 19 in 2013

    Rise in prescription items per person in past decade

    16 JUL 2014 0:00 By Asha Fowells

    Statistics reveal that the average number of prescription items issued per person in England rose from 13 per person per year in 2003 to 19 per person in 2013.

  • Wastewater tests reveal scale of illicit Viagra

    9 JUL 2014 7:21

    Use of sildenafil (Viagra) supplied illicitly prevails over use of legitimately prescribed drug in the Netherlands, researchers warn. The consumption of illicit erectile dysfunction drugs might dwarf the consumption of the legitimately dispensed versions, say the authors, and call for further action against the thousands of “rogue online pharmacies”.

  • A man injecting himself with insulin

    Study raises concern over insulin as addition to metformin for diabetes control

    13 JUN 2014 12:22

    Diabetes patients who use insulin instead of a sulfonylurea — after failing to respond adequately to metformin — are at increased risk of a heart attack, results of a study published in JAMA suggest.

  • SMC appraisal decisions

    12 JUN 2014 10:18

    Budesonide gastro-resistant granules (Budenofalk) have been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC). The indication is the induction of remission in patients with mild to moderate active Crohn’s disease affecting the ileum or ascending colon.

  • Relvar Ellipta

    Relvar Ellipta’s benefits unclear in COPD treatment

    11 JUN 2014 0:00

    There is insufficient evidence to recommend Relvar Ellipta over existing inhaled corticosteroid and long-acting beta2 agonist combinations, says DTB

  • Afinitor Subscription

    9 JUN 2014 15:47

    Patients taking concomitant ACE inhibitor therapy may be at increased risk for angioedema according to the summary of product characteristics for Afinitor (everolimus; Novartis).  

  • Healthcare at Home website

    Regulator gives Healthcare at Home until July to sort medicines supply

    4 JUN 2014 18:04

    Healthcare at Home was inspected in April by the General Pharmaceutical Council and other regulators

  • Encouraging survival data for new melanoma drugs

    4 JUN 2014 17:26

    Concurrent treatment with nivolumab and ipilimumab for patients with advanced melanoma results in overall survival of 82% and 75% at one year and two years, respectively, reveals follow-up of a phase Ib study.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.